Acceptability of HIV Oral Pre-Exposure Prophylaxis (PrEP) Among Men Have Sex With Men (MSM) and Transgender Women (TGW)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Patient Acceptance of Health Care
- Sponsor
- Chiang Mai University
- Enrollment
- 105
- Locations
- 1
- Primary Endpoint
- Acceptability and factors affecting the decision to take oral PrEP
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this study is to determine the factors associated with acceptability to oral HIV pre-exposure prophylaxis (PrEP) among Thai men who have sex with men (MSM) and transgender women (TGW).
Investigators
Suwat Chariyalertsak
MD., Dr.PH
Chiang Mai University
Eligibility Criteria
Inclusion Criteria
- •MSM or TGW at age18 years or older at enrollment
- •Able to read and write effectively in Thai language
- •Negative HIV testing (by assigned rapid tests) at enrollment
- •Available to return for the study visits and willing to comply with study requirements
- •Willing to provide reachable contact numbers and address
- •Creatinine clearance ≥ 60 mL/min
- •Negative urine protein
- •Negative HBs Ag
Exclusion Criteria
- •Symptoms suggestive for acute HIV seroconversion
- •Participating in any interventional HIV research
- •Has any physical or mental condition(s) that, in the opinion of the investigator(s), complicate interpretation of study outcome data
Outcomes
Primary Outcomes
Acceptability and factors affecting the decision to take oral PrEP
Time Frame: 1 year
After receiving information about PrEP, the participants will have a chance to decide whether they want to take PrEP or not. The set of questions asking about reason(s) for taking (or not taking) PrEP are used to evaluated the acceptability. The questions will evaluate multiple aspects such as knowledge about PrEP (efficacy and medications side effect), personal belief about PrEP, sexual practice, social stigmata, and concern for HIV resistance. The participants will answer these questions via Computer-Assisted Self Interviewing (CASI).
Secondary Outcomes
- Adherence to PrEP by self-report(1 year)
- Adherence to PrEP by pill count(1 year)